Plus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Sims Andrew John Hugh MacIntyre
Plus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer HEDRICK MARC H
Plus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Petersen Greg
Plus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Clowes Howard
Plus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Hawkins Richard J
Plus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Lenk Robert P
Plus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Clowes Howard
Plus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer LaFrance Norman D.
Plus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer HEDRICK MARC H
Plus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Sims Andrew John Hugh MacIntyre
Plus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Lenk Robert P
Plus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director van Es-Johansson An
Plus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Hawkins Richard J
Plus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Petersen Greg
Plus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Chief Executive Officer HEDRICK MARC H
Plus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Lenk Robert P
Plus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Lenk Robert P
Plus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Lenk Robert P
Plus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Lenk Robert P
Plus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Clowes Howard
No Data